Population Pharmacokinetics of Ropeginterferon Alfa-2b: A Comparison Between Healthy Caucasian and Chinese Subjects
Objective: To develop a population pharmacokinetic (PK) model for ropeginterferon alfa-2b and to compare its PK properties between Caucasian and Chinese populations.Methods: A population PK model was developed based on data from two phase I clinical trials conducted in Caucasian and Chinese individu...
Saved in:
Main Authors: | Min Zhu (Author), Mei-xia Wang (Author), Zi-ran Li (Author), Wei Wang (Author), Xia Su (Author), Zheng Jiao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b
by: Albert Qin, et al.
Published: (2024) -
Comparison of Pharmacokinetics of Aprepitant in Healthy Chinese and Caucasian Subjects
by: Yang MJ, et al.
Published: (2020) -
Cost-effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera
by: Aaron T Gerds, et al.
Published: (2023) -
Population pharmacokinetic analysis of transdermal granisetron in healthy Chinese and Caucasian volunteers
by: Jiayu Li, et al.
Published: (2023) -
Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
by: Frost C, et al.
Published: (2018)